Medications - Page 80

December 12, 2016

Generic copy of Roche flu pill Tamiflu hits US market

The first generic copy of Roche's top-selling flu pill Tamiflu hit the U.S. market on Monday, marking a further step in the Swiss drugmaker's enforced evolution to reliance on a new wave of blockbuster medicines.

December 9, 2016

Dr. Manny: 5 steps Trump can take to help curb the opioid epidemic in America

Before Donald Trump became president-elect of the United States, I declared my support for his proposed efforts to help curb the tragic opioid abuse epidemic our nation is facing today.

December 9, 2016

A grim tally soars: More than 50K overdose deaths in US

More than 50,000 Americans died from drug overdoses last year, the most ever.

December 7, 2016

EU clears Bristol-Myers immunotherapy drug for blood cancer

Bristol-Myers Squibb's immunotherapy drug Opdivo has been approved in Europe for the treatment of classical Hodgkin lymphoma, a rare blood cancer, the U.S. company said on Wednesday.

December 7, 2016

Pfizer fined for hiking epilepsy drug price 2,600 percent in UK

British regulators fined U.S. drugmaker Pfizer and distributor Flynn Pharma a record 89.4 million pounds ($112.7 million) Wednesday for increasing the cost of an epilepsy drug by as much as 2,600 percent.

December 7, 2016

10 reasons your eyes are bloodshot

Red eyes can spark a lot of annoying questions from people wondering if you’re sick, upset, or hungover.

December 7, 2016

5 reasons your gums bleed when you brush

The night before a teeth cleaning, most of us like to get in there deep.

December 6, 2016

Global prescription drug spend seen at $1.5T in 2021: report

Global spending on prescription medicines will reach nearly $1.5 trillion by 2021, although the annual rate of growth will decrease from recent years, according to a forecast by Quintiles IMS Holding released on Tuesday.

December 6, 2016

Doctors see regular misuse of antibiotics, narcotics

Antibiotics and narcotics are often prescribed when they aren't the best option for patients and may do more harm than good, a survey of U.S. physicians suggests.

December 6, 2016

AstraZeneca pill slashes lung cancer progression in study

AstraZeneca's pill Tagrisso cut the risk of lung cancer progressing by 70 percent compared to standard chemotherapy in a major clinical trial, lifting prospects for a drug that is key to the company's ambitious long-term sales goals.